Discontinued — last reported Q3 '24
Other foreign countries — Revenue
Eli Lilly Other foreign countries — Revenue decreased by 8.1% to $1.11B in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 42.0%, from $780.30M to $1.11B. Over 2 years (FY 2021 to FY 2023), Other foreign countries — Revenue shows relatively stable performance with a 4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product adoption and market expansion in these secondary international regions, while a decrease may signal competitive pressure or regulatory challenges in those specific markets.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products within the geographic segment designat...
Peer comparison
Peers often report this as 'Rest of World' or 'Other International' revenue, which typically represents a smaller, stable portion of total global sales compared to primary markets like the US or Europe.
lly_segment_other_foreign_countries_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $638.10M | $689.40M | $765.60M | $751.50M | $645.70M | $632.00M | $822.80M | $673.10M | $748.50M | $780.30M | $744.30M | $892.90M | $1.21B | $1.11B |
| QoQ Change | — | +8.0% | +11.1% | -1.8% | -14.1% | -2.1% | +30.2% | -18.2% | +11.2% | +4.2% | -4.6% | +20.0% | +35.1% | -8.1% |
| YoY Change | — | — | — | — | +1.2% | -8.3% | +7.5% | -10.4% | +15.9% | +23.5% | -9.5% | +32.7% | +61.1% | +42.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other foreign countries — revenue?
- Eli Lilly (LLY) reported other foreign countries — revenue of $1.11B in Q3 2024.
- How has Eli Lilly's other foreign countries — revenue changed year-over-year?
- Eli Lilly's other foreign countries — revenue increased by 42.0% year-over-year, from $780.30M to $1.11B.
- What is the long-term trend for Eli Lilly's other foreign countries — revenue?
- Over 2 years (2021 to 2023), Eli Lilly's other foreign countries — revenue has grown at a 4.4% compound annual growth rate (CAGR), from $2.70B to $2.95B.
- What does other foreign countries — revenue mean?
- Total revenue generated from sales in international markets not classified as primary geographic segments.